[Malignant dopaminergic syndrome]

Med Clin (Barc). 2004 Apr 3;122(12):477. doi: 10.1157/13060001.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Dopamine Agents / administration & dosage
  • Dopamine Agents / adverse effects*
  • Female
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / adverse effects*
  • Neuroleptic Malignant Syndrome* / diagnosis
  • Neuroleptic Malignant Syndrome* / therapy
  • Parkinson Disease / drug therapy*

Substances

  • Dopamine Agents
  • Levodopa